Evidence map›Paper›PMID 18635357›Full record

ArticleCurrent biology : CB2008

ced-4 and proto-oncogene tfg-1 antagonistically regulate cell size and apoptosis in C. elegans.

Ling Chen, Tom McCloskey, Pradeep M Joshi, Joel H Rothman

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Unzipping the defense: a comprehensive review on bZIP transcription factors inFrontiers in cellular and infection microbiology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ling ChenDepartment of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA.
Tom McCloskey
Pradeep M Joshi
Joel H Rothman
University of California, Santa Barbara · US

Funding

Regulation of apoptosis in C. elegansR01AG023321 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI ROTHMAN, JOEL H. · 2004 to 2008
$1.6M
Function of a membrane-localized nuclear receptorR01HD049805 · NICHD · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI ROTHMAN, JOEL H. · 2006 to 2010
$1.6M
Specification and differentiation of endoderm in C. elegansR01HD062922 · NICHD · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI ROTHMAN, JOEL H. · 2009 to 2013
$1.4M
NIA NIH HHS R01 AG023321NICHD NIH HHS R01 HD049805NICHD NIH HHS R01 HD062922
6 · The paper itself

Abstract

backgroundCell-size-control systems, coupled with apoptotic- and cell-proliferation-regulatory mechanisms, determine the overall dimensions of organs and organisms, and their dysregulation can lead to tumor formation. The interrelationship between cell-growth-regulatory mechanisms and apoptosis during normal development and cancer is not understood. The TRK-fused gene (TFG) promotes tumorigenesis when present in chromosomal rearrangements from various human-cancer types by unknown mechanisms. Apaf1/CED-4 is essential for apoptosis but has not been shown to function in cell-growth control.

resultsWe found that loss of TFG-1, the TFG ortholog in Caenorhabditis elegans, results in supernumerary apoptotic corpses, whereas its overexpression is sufficient to inhibit developmentally programmed cell death. TFG-1 is also required for cells and nuclei to grow to normal size. Furthermore, we found that CED-4 is required for cell-growth inhibition in animals lacking TFG-1. However, caspases, the downstream effectors of CED-4-mediated apoptosis, are not required in TFG-1- or CED-4-regulated cell-size control. CED-4 acts to inhibit cell growth by antagonizing the effects of other conserved cell-size-regulating proteins, including cAMP response element binding (CREB) protein, translation-initiation factor eIF2B, and the nucleolar p53-interacting protein nucleostemin.

conclusionsThese findings show that TFG-1 suppresses apoptosis and is essential for normal cell-size control, suggesting that abnormalities in the cell-growth-promoting and apoptosis-inhibiting functions of TFG might be responsible for its action in tumorigenesis. Also, they reveal that CED-4 plays a pivotal role in activating apoptosis and restricting cell and nuclear size, thereby determining the appropriate overall size of an animal. Thus, these findings reveal links between the control mechanisms for apoptosis and cell growth.

Indexed as

AnimalsApoptosisBody SizeCaenorhabditis elegansCaenorhabditis elegans ProteinsCalcium-Binding ProteinsCell SizeCyclic AMP Response Element-Binding ProteinEukaryotic Initiation Factor-2BGenes, HelminthMembrane ProteinsNuclear ProteinsProto-Oncogene MasProto-OncogenesRNA InterferenceCaenorhabditis elegans ProteinsCalcium-Binding ProteinsCed-4 protein, C elegansCyclic AMP Response Element-Binding Proteindnj-29 protein, C elegansEukaryotic Initiation Factor-2BMAS1 protein, humanMembrane ProteinsNuclear ProteinsProto-Oncogene Mas

Identifiers

PMID18635357
PMCPMC3142714
OpenAlexW2147871069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.